
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZNF584 (zinc finger protein 584) encodes a predicted zinc finger transcription factor that may bind specific cis-regulatory regions associated with RNA polymerase II-dependent transcription. Through sequence-specific DNA binding, ZNF584 is predicted to participate in regulation of gene expression in the nucleus. The available annotation does not establish specific target genes, cellular pathways, or physiological functions, and its molecular mechanisms remain incompletely characterized.
A human gastric tubular adenocarcinoma cell line established from a nude mouse xenograft of metastatic liver tissue. The cells were derived from a male donor and are classified as a gastric cancer cell line.
Each knockout cell line is validated by STR authentication, sterility testing (bacteria/fungi), and mycoplasma screening. Genotype is confirmed by two rounds of PCR and Sanger sequencing. Only clones that pass all QC criteria are released, ensuring reliable identity and performance for downstream applications.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 3
Reference Transcript: NM_173548
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?